Im. Hoepelman et al., SAFETY AND EFFICACY OF LOMEFLOXACIN VERSUS NORFLOXACIN IN THE TREATMENT OF COMPLICATED URINARY-TRACT INFECTIONS, European journal of clinical microbiology & infectious diseases, 12(5), 1993, pp. 343-347
Seventy patients with complicated urinary tract infections were treate
d with either lomefloxacin (400 mg once daily) or norfloxacin (400 mg
twice daily) for 10 to 14 days. A total of 19 (86 %) of 22 patients tr
eated with lomefloxacin and 20 (74 %) of 27 patients treated with norf
loxacin were cured, as defined by a negative culture five to nine days
after completion of therapy (p = 0.09). After four to six weeks, the
figures were 56 % for lomefloxacin and 48 % for norfloxacin. Adverse e
ffects in the lomefloxacin group were observed on 20 occasions in 12 p
atients (one stopped treatment) compared to nine occasions in five pat
ients treated with norfloxacin (difference not significant).